Aura Biosciences, Inc. (AURA)
7.185
-0.18
(-2.38%)
USD |
NASDAQ |
Sep 09, 16:00
7.185
0.00 (0.00%)
After-Hours: 16:48
Aura Biosciences Total Liabilities (Quarterly) : 32.86M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.86M |
| March 31, 2026 | 30.43M |
| December 31, 2025 | 183.06M |
| September 30, 2025 | 33.36M |
| June 30, 2025 | 29.77M |
| March 31, 2025 | 27.44M |
| December 31, 2024 | 30.53M |
| September 30, 2024 | 30.67M |
| June 30, 2024 | 26.83M |
| March 31, 2024 | 26.24M |
| December 31, 2023 | 29.23M |
| September 30, 2023 | 28.05M |
| Date | Value |
|---|---|
| June 30, 2023 | 26.30M |
| March 31, 2023 | 25.76M |
| December 31, 2022 | 28.35M |
| September 30, 2022 | 28.09M |
| June 30, 2022 | 5.93M |
| March 31, 2022 | 5.336M |
| December 31, 2021 | 7.715M |
| September 30, 2021 | 6.415M |
| June 30, 2021 | 6.10M |
| March 31, 2021 | 3.983M |
| December 31, 2020 | 2.741M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 348.13M |
| Shareholders Equity (Quarterly) | 315.27M |
| Debt to Equity Ratio | 0.0526 |
| Current Ratio | 16.82 |
| Net Debt Paydown Yield | 0.05% |